Journals / Turkish Journal of Biology / 2016 / Cilt: 40 - Sayı: 2

Effects of amniotic fluid mesenchymal stem cells in carboxymethyl cellulosegel on healing of spontaneous pressure sores: clinical outcome in sevenhospitalized neonatal foals

Pages
484–492
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that the mean sore regression rate with AFMSCs in CMC gel was statistically higher than the mean value recorded in the control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the present study, an innovative therapy for spontaneously arisen pressure sores in seven hospitalized neonatal foals is described, using mesenchymal stem cells obtained from equine amniotic fluid.
📊
Key Findings & Data:The results showed that the mean sore regression rate with AFMSCs in CMC gel was statistically higher than the mean value recorded in the control group.
💡
Conclusion & Impact:The results suggest that local application of mesenchymal stem cells isolated from amniotic fluid, using CMC as scaffold, could be considered as an effective treatment of deep sores in hospitalized neonatal foals.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In the present study, an innovative therapy for spontaneously arisen pressure sores in seven hospitalized neonatal foals is described, using mesenchymal stem cells obtained from equine amniotic fluid. Amniotic fluid mesenchymal stem cells (AFMSCs) were isolated from fluid samples recovered at delivery. Heterologous cells, at passage three of in vitro culture, were applied to sores twice a week for four consecutive times in a carboxymethylcellulose (CMC) gel. As a control, a commercial ointment was used. The results showed that the mean sore regression rate with AFMSCs in CMC gel was statistically higher than the mean value recorded in the control group. This was associated with a significant effect of the treatment used and a statistically significant effect of treatment over time. The results suggest that local application of mesenchymal stem cells isolated from amniotic fluid, using CMC as scaffold, could be considered as an effective treatment of deep sores in hospitalized neonatal foals.

🔖

Cite This Article

IANOCCO, E., LANCI, A., MERLO, B., RICCI, F., PIRRONE, A., ANTONELLI, C., MARIELLA, J., CASTAGNETTI, C. (2022). Effects of amniotic fluid mesenchymal stem cells in carboxymethyl cellulosegel on healing of spontaneous pressure sores: clinical outcome in sevenhospitalized neonatal foals. Turkish Journal of Biology, Cilt: 40 - Sayı: 2, 484–492. https://ajindex.com/articles/654417

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Adam EN, Southwood LL (2006). Surgical and traumatic wound infections, cellulitis, and myositis in horses. Vet Clin North Am Equine Pract 22: 335–361.
  2. Agrawal K, Chauhan N (2012). Pressure ulcers: back to the basics. Indian J Plast Surg 45: 244–254.
  3. Balaji S, Keswani SG, Crombleholme TM (2012). The role of mesenchymal stem cells in the regenerative wound healing phenotype. Adv Wound Care 1: 159–165.
  4. Balbino CA, Pereira LM, Curi R (2005). Mechanisms involved in wound healing: a revision. Rev Bras Cienc Farm 41: 27–51.
  5. Bluestein D, Javaheri A (2008). Pressure ulcers: prevention, evaluation, and management. Am Fam Physician 78: 1186– 1194. Cochrane CA, Pain R, Knottenbelt DK (2003). In-vitro wound contraction in the horse: differences between body and limb wounds. Wounds 15: 175–181.
  6. De Coppi P, Bartsch G, Siddiqui M, Xu T, Santos C, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100–106.
  7. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315–317.
  8. Fader M, Clarke-O’Neill S, Cook D (2003). Management of night time urinary incontinence in residential settings for older people: an investigation into the effects of different pad changing regimes on skin health. J Clin Nurs 12: 374–386.
  9. Ferrell B, Artinian B, Sessing D (1995). The Sessing Scale for assessment of pressure ulcer healing. J Am Geriatr Soc 43: 37–40.
  10. Fuchs E, Horsley V (2008). More than one way to skin. Genes Dev 22: 976–985.
  11. Gianaroli L, Carai P, Stanghellini I, Ferraretti A, Magli M (2009). Le cellule staminali: dalla ricerca all’applicazione clinica. Rome, Italy: Repronews, Organo Ufficiale della Società Italiana di Riproduzione (in Italian). Hendrickson DA (2011). Management of deep and chronic wounds. In: Auer J, Stick J, editors. Equine Surgery. 4th ed. St. Louis, MO, USA: Saunders, pp. 317–323.
  12. Iacono E, Brunori L, Pirrone A, Pagliaro P, Ricci F, Tazzari P, Merlo B (2012a). Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton’s jelly in the horse. Reproduction 143: 455–468.
  13. Iacono E, Merlo B, Pirrone A, Antonelli C, Brunori L, Romagnoli N, Castagnetti C (2012b). Effects of mesenchymal stem cells